Mgr. Zbyněk Bortlíček
Researcher, Institute of Biostatistics and Analyses
Correspondence Address:
Kamenice 753/5, 625 00 Brno
E‑mail: |
---|
Total number of publications: 193
2017
-
Stav léčby pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2017
Year: 2017, type: Conference abstract
-
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
BMC Cancer, year: 2017, volume: 17, edition: 880, DOI
2016
-
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
Anticancer Research, year: 2016, volume: 36, edition: 9, DOI
-
Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice
Drugs & Aging, year: 2016, volume: 33, edition: 9, DOI
-
Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC
Anticancer Research, year: 2016, volume: 36, edition: 1
-
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
Tumor Biology, year: 2016, volume: 37, edition: 5, DOI
-
Gefitinib in first-line treatment of caucasian patients with NSCLC and EGFR Mutations in Exons 19 or 21
Year: 2016, type: Conference abstract
-
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
Anticancer Research, year: 2016, volume: 36, edition: 5
-
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
Leukemia & Lymphoma, year: 2016, volume: 57, edition: 5, DOI
-
Léčba pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2016 (aktuální stav, srovnání se zahraničím, výhled do budoucna)
Year: 2016, type: Conference abstract